Dr. Robert Alan Goldberg, MD

Dr. Goldberg practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Goldberg's NPI, 1033123203, was assigned on July 27, 2006. Dr. Goldberg graduated from David Geffen School of Medicine at UCLA in 1983. Dr. Goldberg holds California license G52591.

Dr. Goldberg's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Goldberg's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Goldberg is also affiliated with Ronald Reagan UCLA Medical Center. Dmand AI also links Dr. Goldberg to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldberg practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Goldberg's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Goldberg is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Goldberg's licenses on file in 2 states: California and Nevada.

Dmand AI lists dry eye, eye infection or inflammation, eyelid inflammation and vision problems among the conditions Dr. Goldberg treats.

CMS data shows 4,277 Medicare services from Dr. Goldberg across 12 procedure codes in 2024, for 486 Medicare patients. Medicare paid $97,285 for them.

CMS counts 486 Medicare patients who saw Dr. Goldberg in 2024. The largest group is 65 to 74, with 200 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goldberg's median patient age at 70, with 59% women.

In 2024, Dr. Goldberg wrote 280 Medicare Part D claims for 160 patients. 91% of them were for generic drugs. CMS names the drug for 228 of them, across 5 drugs with 11 or more claims each, at $3,063 in total drug cost. In 2023, CMS named 165 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Goldberg for performance year 2024, reported as part of a group. Dr. Goldberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goldberg as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Goldberg, published from 2010 to 2025. The most frequent topics are Blepharoplasty, Eyelid Diseases and Eyelids. Dr. Goldberg has published most often in Ophthalmic Plast Reconstr Surg. Dr. Goldberg's most frequent co-authors are Daniel Benson Rootman, FRCSC, MD, MS, Babak Azizzadeh, MD and Christine Lynn Bokman, MD.

CMS Open Payments shows 69 general payments to Dr. Goldberg from 17 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 78% of the total. Allergan Inc. paid the most, $1,104.

Dmand AI lists 3 awards for Dr. Goldberg.

Dr. Goldberg graduated from David Geffen School of Medicine at UCLA in 1983. Dr. Goldberg is a member of AAO and ACS.

Dr. Goldberg is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.